Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
Fedorinov DS, Mirzaev KB, Ivashchenko DV, Temirbulatov II, Sychev DA, Maksimova NR, Chertovskih JV, Popova NV, Tayurskaya KS, Rudykh ZA. Fedorinov DS, et al. Among authors: ivashchenko dv. Drug Metab Pers Ther. 2018 Jun 27;33(2):91-98. doi: 10.1515/dmpt-2018-0004. Drug Metab Pers Ther. 2018. PMID: 29738309
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V. Sychev D, et al. Drug Metab Pers Ther. 2020 Mar 5;35(1):/j/dmdi.2020.35.issue-1/dmpt-2019-0029/dmpt-2019-0029.xml. doi: 10.1515/dmpt-2019-0029. Drug Metab Pers Ther. 2020. PMID: 32134727
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban.
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. Sychev DA, et al. Among authors: ivashchenko dv. Pharmgenomics Pers Med. 2020 Jan 23;13:29-37. doi: 10.2147/PGPM.S234910. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32158254 Free PMC article.
Pain pharmacogenetics.
Slepukhina MA, Ivashchenko DV, Sheina MA, Muradian AA, Blagovestnov DA, Sychev DA. Slepukhina MA, et al. Among authors: ivashchenko dv. Drug Metab Pers Ther. 2020 Aug 10;35(3). doi: 10.1515/dmpt-2020-2939. Drug Metab Pers Ther. 2020. PMID: 32776897 Review.
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation.
Ivashchenko DV, Khoang SZ, Makhmudova BV, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Shuev GN, Dorina IV, Nastovich MI, Shagovenko EN, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Ivashchenko DV, et al. Drug Metab Pers Ther. 2020 Aug 24;35(4). doi: 10.1515/dmpt-2020-0102. Drug Metab Pers Ther. 2020. PMID: 32827391
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
Ivashchenko DV, Yudelevich DA, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Kachanova AA, Dorina IV, Nastovich MI, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Ivashchenko DV, et al. Drug Metab Pers Ther. 2021 Aug 12. doi: 10.1515/dmdi-2021-0124. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34388331
29 results